Bespoke Extracts (BSPK) Total Current Liabilities (2011 - 2025)
Bespoke Extracts (BSPK) reported Total Current Liabilities of $1.9 million for Q3 2025, up 8.38% on a YoY basis from $1.7 million in Q3 2024, and up 26.06% sequentially from $1.5 million in Q2 2025.
Bespoke Extracts (BSPK) Total Current Liabilities (2011 - 2025) Analysis & Trends
Bespoke Extracts (BSPK) has 15 years of Total Current Liabilities data on file, last reported at $1.9 million in Q3 2025.
- For the quarter ending Q3 2025, Total Current Liabilities rose 8.38% year-over-year to $1.9 million; the trailing twelve-month figure through Sep 2025 stood at $1.9 million (up 8.38% YoY), and the FY2024 full-year result was $1.1 million, up 3.68% from the prior year.
- Total Current Liabilities grew to $1.9 million in Q3 2025, from $1.5 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $1.9 million in Q3 2025 to a low of $146830.0 in Q4 2021.
- A 5-year average of $956223.4 and a median of $925281.0 in 2023 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities plunged 79.05% in 2021 and jumped 416.29% in 2023, its largest moves.
- Tracing BSPK's Total Current Liabilities over 5 years: stood at $146830.0 in 2021, then jumped by 489.56% to $865648.0 in 2022, then climbed by 24.64% to $1.1 million in 2023, then gained by 3.68% to $1.1 million in 2024, then soared by 67.39% to $1.9 million in 2025.
- Business Quant data shows BSPK's Total Current Liabilities at $1.9 million in Q3 2025, $1.5 million in Q2 2025, and $1.2 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.56 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.53 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 18.06 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 599.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 6.81 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 831.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.66 Bn |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 | 1.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.87 Mn |
| Jun 30, 2025 | 1.49 Mn |
| Mar 31, 2025 | 1.24 Mn |
| Dec 31, 2024 | 1.12 Mn |
| Sep 30, 2024 | 1.73 Mn |
| Jun 30, 2024 | 1.57 Mn |
| Mar 31, 2024 | 1.35 Mn |
| Dec 31, 2023 | 1.08 Mn |
| Sep 30, 2023 | 925,281.00 |
| Jun 30, 2023 | 758,064.00 |
| Mar 31, 2023 | 1.25 Mn |
| Dec 31, 2022 | 865,648.00 |
| Sep 30, 2022 | 519,171.00 |
| Jun 30, 2022 | 296,819.00 |
| Mar 31, 2022 | 241,900.00 |
| Nov 30, 2021 | 146,830.00 |
| Aug 31, 2021 | 542,762.00 |
| May 31, 2021 | 562,670.00 |
| Feb 28, 2021 | 616,462.00 |
| Nov 30, 2020 | 701,018.00 |